Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You Zhai

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Frontiers in Cell and Developmental Biology|December 16, 2021
Molecular Characterization and Clinical Relevance of <i>ANXA1</i> in Gliomas <i>via</i> 1,018 Chinese Cohort PatientsZenghui Qian, Wenhua Fan, Fanlin Meng, et al.
Journal of the National Cancer Institute|November 9, 2023
Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastomaChangqing Pan, You Zhai, Chen Wang, et al.
Frontiers in Pharmacology|July 30, 2019
A Phase I Comparative Pharmacokinetic and Safety Study of Two Intravenous Formulations of Vinorelbine in Patients With Advanced Non-Small Cell Lung CancerGuolan Wu, Lihua Wu, Huili Zhou, et al.
Aging|July 24, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastomaGuanzhang Li, You Zhai, Hanjie Liu, et al.
Cancer Science|December 9, 2021
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samplesWang Di, Wenhua Fan, Fan Wu, et al.
Expert Opinion on Investigational Drugs|July 11, 2024
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjectsJian Liu, Qingwei Zhao, You Zhai, et al.
Ebiomedicine|December 16, 2022
Immunological profiles of human oligodendrogliomas define two distinct molecular subtypesFan Wu, Yi-Yun Yin, Wen-Hua Fan, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 2, 2020
Tianma Gouteng Decoction Exerts Cardiovascular Protection by Upregulating OPG and TRAIL in Spontaneously Hypertensive RatsLin-Hua Deng, Lan Li, You Zhai, et al.
ACS Sensors|March 9, 2026
Wireless Miniaturized Electromechanical System Enables Real-Time Biomechanical Monitoring of Aortic AneurysmYiqiang Li, Chi Zhang, Xiangyu Zong, et al.
BMC Nephrology|July 10, 2026
Safety, pharmacokinetic, and pharmacodynamic characteristics of SK-08, a soluble guanylate cyclase activator, after oral administration in healthy participants: a randomized phase 1 trialJian Liu, Ying Du, Hong Zhou, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Frontiers in Cell and Developmental Biology|December 16, 2021
Molecular Characterization and Clinical Relevance of <i>ANXA1</i> in Gliomas <i>via</i> 1,018 Chinese Cohort PatientsZenghui Qian, Wenhua Fan, Fanlin Meng, et al.
Journal of the National Cancer Institute|November 9, 2023
Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastomaChangqing Pan, You Zhai, Chen Wang, et al.
Frontiers in Pharmacology|July 30, 2019
A Phase I Comparative Pharmacokinetic and Safety Study of Two Intravenous Formulations of Vinorelbine in Patients With Advanced Non-Small Cell Lung CancerGuolan Wu, Lihua Wu, Huili Zhou, et al.
Aging|July 24, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastomaGuanzhang Li, You Zhai, Hanjie Liu, et al.
Cancer Science|December 9, 2021
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samplesWang Di, Wenhua Fan, Fan Wu, et al.
Expert Opinion on Investigational Drugs|July 11, 2024
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjectsJian Liu, Qingwei Zhao, You Zhai, et al.
Ebiomedicine|December 16, 2022
Immunological profiles of human oligodendrogliomas define two distinct molecular subtypesFan Wu, Yi-Yun Yin, Wen-Hua Fan, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 2, 2020
Tianma Gouteng Decoction Exerts Cardiovascular Protection by Upregulating OPG and TRAIL in Spontaneously Hypertensive RatsLin-Hua Deng, Lan Li, You Zhai, et al.
ACS Sensors|March 9, 2026
Wireless Miniaturized Electromechanical System Enables Real-Time Biomechanical Monitoring of Aortic AneurysmYiqiang Li, Chi Zhang, Xiangyu Zong, et al.
BMC Nephrology|July 10, 2026
Safety, pharmacokinetic, and pharmacodynamic characteristics of SK-08, a soluble guanylate cyclase activator, after oral administration in healthy participants: a randomized phase 1 trialJian Liu, Ying Du, Hong Zhou, et al.
Pageof 11